IFP Advisors’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
BBA
IFP Advisors's PRAX Position: Q3 2026 in Review
IFP Advisors increased its Praxis Precision Medicines (PRAX) stake by 632% in Q3 2026, buying an estimated $52.3K and bringing the position to 183 shares worth $53.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2358.
IFP Advisors first reported a position in PRAX in Q3 2023 and has held it in 8 quarters since. 338 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.
- IFP Advisors held 183 shares of Praxis Precision Medicines worth $53.3K as of Q3 2026.
- IFP Advisors bought 158 Praxis Precision Medicines shares in Q3 2026, an estimated $52.3K.
- Praxis Precision Medicines made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #2358 holding.
- IFP Advisors first reported a position in Praxis Precision Medicines in Q3 2023 and has held it in 8 quarters since.
- 338 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.
Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.